Live Breaking News & Updates on Patients With Ovarian Cancer

Stay updated with breaking news from Patients with ovarian cancer. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Research identifies predictor of outcomes, chemoresistance for ovarian cancer patients

Research identifies predictor of outcomes, chemoresistance for ovarian cancer patients
medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.

Baden Wüberg , Martina Bazzaro , Emil Lou , M Medical School , University Of Tubingen , Association Of Tumor , Masonic Cancer Center , Karolinska Institute , M Health Fairview , University Of Minnesota Masonic Cancer Center , Tumor Stroma Proportion , Clinical Outcomes , Patients With Ovarian Cancer , Cancer Genome Atlas , Cohort The , Predict Chemoresistance ,

Dr DeBernardo on the Use of Later-Line Maintenance Therapy in Ovarian Cancer

Robert DeBernardo, MD, discusses the use of maintenance therapy in the second- and later-line settings for patients with ovarian cancer. ....

Robert Debernardo , Women Health Institute , Health Institute , Cleveland Clinic , Patients With Ovarian Cancer ,

Dr Crafton on the Use of Mirvetuximab Soravtansine in Ovarian Cancer

Sarah Crafton, MD, discusses the potential future of antibody-drug conjugates in patients with ovarian cancer. ....

Sarah Crafton , Allegheny Health Network , Antibody Drug Conjugates , Patients With Ovarian Cancer ,

Dr Markman on Pragmatic Clinical Trial Designs in Ovarian Cancer

Maurie Markman, MD, discusses the importance of designing clinical trials for patients with ovarian cancer that are based on real-world data and consider the increasing complexity of treatment sequencing in this disease. ....

United States , Maurie Markman , Hope Atlanta , City Of Hope Atlanta , End Phoenix , Patients With Ovarian Cancer ,

Dendritic Cell Vaccines Represent Potential Avenue to Enhance Immunotherapy in Ovarian Cancer

Martin Cannon, PhD, delves into ongoing research on the use of dendritic cell vaccines to generate Th17 responses in patients with ovarian cancer and details how this could address a need for select patients with ovarian cancer. ....

Little Rock , College Of Medicine , University Of Arkansas , National Cancer Institute , Martin Cannon , Science Summit , Medical Sciences , New England Journal , Patients With Ovarian Cancer , Dendritic Cell Vaccines , The University Of Arkansas For Medical Sciences ,